Source: Guideline 1999
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K.F. Chung, P. Godard, et al.. Difficult/therapy - resistant asthma. Guideline 1999

Member's Comments

No comment yet.

Related content which might interest you: Do inhaled corticosteroids reduce the frequent exacerbator phenotype in COPD - A little help by a multicenter survey Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Higher doses of inhaled steroid are associated with bacterial bronchitis in children with severe therapy resistant asthma (STRA) Source: International Congress 2016 – Paediatric asthma: from amniotic fluid to dirty streets Year: 2016 Prevalence of therapeutic resistant and steroid resistant bronchial asthma in children and adolescents Source: Eur Respir J 2005; 26: Suppl. 49, 681s Year: 2005 Genetic determinants of oropharyngeal streptococci antimicrobial resistance in COPD patients and asthma sufferers Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 Bacterial resistance induction with prophylactic antibiotics in COPD Source: International Congress 2014 – COPD markers Year: 2014 Wet cough in paediatric severe therapy resistant asthma (STRA) Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Prevalence of refractory asthma in population with severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Fungal sensitisation in children with severe therapy resistant asthma Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood Year: 2012 MUC1-CT mediates corticosteroid responses in COPD Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Prevalence and characteristics of the asthma-COPD overlap syndrome - or the asthma-like COPD phenotype - in a COPD high risk population Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Small airways targeting of inhaled steroids for severe therapy resistant asthma in children Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Scond may better discriminate severe therapy resistant asthma (STRA) from mild-moderate asthma than lung clearance index (LCI) Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease Year: 2016 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 TB infection decreases asthma prevalence and severity of symptoms Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Symptom profile of exacerbations in earlier and later COPD Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 CAT in COPD phenotypes (POPE study) Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016